SEC Form 4 · accession 0001091818-26-000133
BIOFORCE NANOSCIENCES HOLDINGS, INC. · BFNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kaiser Kaiser
Officer — CEO & CFO · Director
Period of report
Apr 20, 2026
Accepted (ET)
Sep 2, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001310488
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock; Par Value $0.001F1 | Apr 20, 2026 | G | 4,132,000 | $0.001 | D | 956,000 | D | |
| Common Stock; Par Value $0.001F2 | Aug 20, 2026 | J | 38,462 | $0.65 | D | 917,538 | D | |
| Common Stock; Par Value $0.001F3 | Aug 31, 2026 | A | 316,909 | $0.55 | A | 1,234,447 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F138,000 shares of this amount are held in YES INTERNATIONAL's name, an LLC that is 100% controlled by the reporting individual
- F2Reporting person paid a residential landscape contractor in shares in lieu of cash on an outstanding promissory note that was entered into in 2020 for the amount of $25,000.
- F3Reporting person received restricted shares in lieu of cash on a portion of accrued wages owed by the Company through April 30, 2026.